AccuRoute’s 2022 Release features expanded Electronic Medical Records (EMR) integrations, Multifunction Printer (MFP) integrations, and learned automation capabilities
AUSTIN, Texas–(BUSINESS WIRE)–Upland Software, Inc. (NASDAQ: UPLD) has announced AccuRoute’s latest 2022 release, which is designed to enhance digital productivity and streamline business-critical workflows through one central interface. With this release, AccuRoute further cements its position as a bridge between customers’ on-premise applications and cloud solutions through critical MFP and EMR integration expansions and new Machine Learning (ML) capabilities that improve data collection and the overall user experience.
“This is a really exciting release for AccuRoute and our users, especially within the healthcare industry, where there is a rising need to put centralized digital capabilities directly into the hands of healthcare providers,” said Shawn Freligh, VP of Product and Chief Technologist for the Document Workflow team at Upland. “Through Epic’s App Orchard*, we can offer healthcare providers more robust fax capabilities directly from Epic, an integration that is now available through AccuRoute, as well as through Upland’s InterFAX SaaS fax product offering.”
Features of AccuRoute’s latest release include:
To learn more about AccuRoute, visit uplandsoftware.com/AccuRoute.
*Epic and App Orchard are trademarks or registered trademarks of Epic Systems Corporation.
About Upland
Upland helps global businesses accelerate digital transformation with a powerful cloud software library that provides choice, flexibility, and value. Our growing library of products delivers the “last mile” plug-in processes, reporting, and job-specific workflows that major cloud platforms and homegrown systems don’t provide. We focus on specific business challenges and support every corner of the organization, operating at scale and delivering quick time to value for our 1,700+ enterprise customers. To learn more, visit www.uplandsoftware.com.
Contacts
Tiffany Young
media@uplandsoftware.com
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the…
Shrivers Hospice sets a benchmark for quality care in Ohio with prestigious award LOS ANGELES,…